The invitation only Benelux platform for tomorrow’s academic Health ventures
Connect with our Human Health community of knowledge institutes, spin-off initiatives, investors and industry partners.
HIHR offers valuable networking opportunities, allowing spin-offs to build up contacts for investments in follow-up programs, as well as a good feedback to sharpen their propositions.
Our practitioner driven network that brings together around hundred investors, spin-offs and TTO-professionals within the Benelux is growing fast.
Public Research Organisations (PRO’s)
Support and networking for your (potential) spin-offs.
Expert sessions, pitchtraining and webinars provide feedback for you and the entrepreneurs you work with.
During the preparations and sessions itself you will get highly valued feedback, preparing you to connect with leading companies and investors in the medical innovation field.
After two years HIHR is happy to reconnect again to Flanders Bio and to organise its 12th pitch-edition in Antwerp on May 31, 2023 with Quickfire sessions scheduled the week before. We settle ourselves again on the eve of Knowledge for Growth and welcome you to the Darwin Hall at Room with a Zoo, located directly next to Antwerp Central Station; all to enable our delegates to join the State of the Union and/or the Knowlegde for Growth event afterwards.
At HIHR 2019 we had the opportunity as an academic team to pitch our spin-off project to a group of investors. After teaming up with an experienced entrepreneur and thorough due diligence, we successfully secured funding from some of those investors.
Great opportunity to get honest feedback from a great panel of experts and investors, even for projects in a rather early stage (QF Sessions).
Sven Arnouts, Ghent University
As an early stage investor, HIHR is a unique opportunity to meet entrepreneurs in life sciences that are motivated to bring their work to patients. In addition, the meeting clearly has an objective to have benefits for all involved. I learned a lot from both presenters as well as questions from the audience.
Kjell Mortier, Novalis Biotech
Participating Public Research Organisations (PROs)
Many leading funds and venture developers are participating in our events. Found out here the list of all investors and industry partners that have joined our pitch sessions.